13F-HR filed by HARVARD MANAGEMENT CO INC
HARVARD MANAGEMENT CO INC filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-12, with 40 holding rows worth $1,706,339,000.
- Accession
- 0000950123-21-014966
- Filer
- CIK 1082621
- Filed
- 2021-11-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2021
A holdings report, 40 entries on the cover page, a total value of $1,706,339,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,706,340,000 with VALUE read as thousands by filing date, 13F file number 028-03879. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Apple Inc | 037833100 | COM | 1,883,445 | $266,507,000 | thousands by filing date | |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 7,142,856 | $258,143,000 | thousands by filing date | |
| META PLATFORMS INC CL A | 30303M102 | COM | 713,073 | $242,010,000 | thousands by filing date | |
| LIGHT & WONDER INC COM | 80874P109 | Stock | 2,678,571 | $222,509,000 | thousands by filing date | |
| Alphabet Inc. Reg. Shares A | 02079K305 | COM | 61,070 | $163,272,000 | thousands by filing date | |
| AFFIRM HLDGS INC COM CL A | 00827B106 | Stock | 753,804 | $89,801,000 | thousands by filing date | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 4,105,095 | $82,266,000 | thousands by filing date | |
| INVESCO QQQ TR | 46090E103 | COM | 101,448 | $36,314,000 | thousands by filing date | |
| RECURSION PHARMACEUTICALS IN | 75629V104 | CL A | 1,509,254 | $34,728,000 | thousands by filing date | |
| ISHARES TR CORE S&P 500 ETF | 464287200 | SHS | 65,342 | $28,151,000 | thousands by filing date | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 186,143 | $27,099,000 | thousands by filing date | |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 1,163,601 | $26,204,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 670,382 | $18,442,000 | thousands by filing date | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 541,124 | $17,062,000 | thousands by filing date | |
| ROCKET LAB USA INC | 773122106 | COM | 1,000,000 | $16,130,000 | thousands by filing date | |
| SPDR GOLD TR | 78463V107 | GOLD SHS | 91,955 | $15,101,000 | thousands by filing date | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 778,517 | $14,395,000 | thousands by filing date | |
| PURECYCLE TECHNOLOGIES INC | 74623V103 | COM | 1,069,600 | $14,204,000 | thousands by filing date | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 673,270 | $13,903,000 | thousands by filing date | |
| GENERATION BIO CO | 37148K100 | COM | 510,354 | $12,795,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 410,714 | $11,586,000 | thousands by filing date | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 498,001 | $11,464,000 | thousands by filing date | |
| MELI KASZEK PIONEER CORP | G5S74L106 | CLASS A ORD | 1,000,000 | $11,050,000 | thousands by filing date | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 562,379 | $9,493,000 | thousands by filing date | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 314,762 | $9,430,000 | thousands by filing date | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 708,385 | $9,159,000 | thousands by filing date | |
| Vanguard FTSE Developed Markets ETF | 921943858 | SHS | 162,699 | $8,215,000 | thousands by filing date | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 229,144 | $5,855,000 | thousands by filing date | |
| Surrozen, Inc. | 86889P109 | COM | 826,852 | $5,854,000 | thousands by filing date | |
| iShares Core S&P Small-Cap ETF | 464287804 | SHS | 49,559 | $5,411,000 | thousands by filing date | |
| PARDES BIOSCIENCES INC COM | 30318F100 | Stock | 400,000 | $3,980,000 | thousands by filing date | |
| VWO | 922042858 | SHS | 73,804 | $3,691,000 | thousands by filing date | |
| IJH | 464287507 | COM | 12,683 | $3,337,000 | thousands by filing date | |
| DECIBEL THERAPEUTICS INC | 24343R106 | COM | 328,798 | $2,535,000 | thousands by filing date | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 332,610 | $2,421,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 107,252 | $1,742,000 | thousands by filing date | |
| GEMINI THERAPEUTICS INC | 36870G105 | CMN | 250,000 | $1,010,000 | thousands by filing date | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 131,847 | $918,000 | thousands by filing date | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 108,333 | $124,000 | thousands by filing date | |
| AMPLITUDE INC COM CL A | 03213A104 | Stock | 540 | $29,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-21-014966 | this filing | 2021-11-12 | acceptance time not in the bulk data set |